Insulet Corporation
Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System
Omnipod 5 is the first tubeless automated insulin delivery (AID) system that integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) System and a compatible smartphone to automatically adjust insulin and help protect against highs and lows.
Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System
Insulet will present new clinical outcomes data for preschool children with type 1 diabetes using the Omnipod 5 Automated Insulin Delivery System (Omnipod 5).
Insulet Presents Omnipod Virtual Care Experience and Pre-Pivotal Study Results at the American Diabetes Association 80th Scientific Sessions
Omnipod 5 Automated Glucose Control System, Powered by Horizon™ (Omnipod 5), formerly known as the Omnipod Horizon System, is the first tubeless smartphone-controlled automated insulin delivery system for people living with diabetes.
Insulet Resumes Pivotal Study of its Next-Generation Product – Omnipod, Powered by Horizon™
Insulet expects to commercialize Omnipod, Powered by Horizon, in the U.S. in the first half of 2021, pending clearance by the FDA.
